Evolution of the share of multiple-source statin prescriptions among all statin prescriptions between 2002 and 2011, France

Sources: Data IMS Health / Permanent Survey on Medical Prescriptions

Calculation and realisation: IRDES

Reading: prescription rates for statins increase within the group of approved multiple-source drugs when a new multiple source molecule is introduced. Since 2006, trends regarding prescriptions of multiple-source statins are rather on the decline, which is perhaps why such prescriptions were backed up by a support policy. Moreover, they also constitute one goal listed in the measure “Remuneration based on public health goals” (Rémunération sur objectif de santé publique, ROSP).

All the charts...